Matthew W. Foehr is President & COO at LIGAND PHARMACEUTICALS INC (LGND). They have made 52 open-market trades across 4 companies since 2006, most recently 2026-04-07.
CIK 0001237556
26 open-market purchases totalling $9.8M since 2012, against 26 sales. Across 26 scored buys the stock is up 1.0% at ninety days, and 1.5 points behind the S&P over the same stretch.
26 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 31% | 27% | 38% |
| Avg Move | -2.6% | -1.6% | +1.0% |
| Alpha | -0.8% | -1.9% | -1.5% |
| Scored | 26 | 26 | 26 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OABI | SELL | 2026-04-07 | 2026-04-07 | $1.49 | $29K | +5.8% | -5.5% | +55.5% |
| OABI | SELL | 2026-02-18 | 2026-02-18 | $1.71 | $53K | +2.9% | +2.3% | +38.3% |
| OABI | SELL | 2026-02-17 | 2026-02-17 | $1.70 | $35K | +1.2% | +8.2% | +34.7% |
| VKTX | SELL | 2026-01-02 | 2026-01-05 | $35.11 | $562K | +0.0% | -7.3% | +6.5% |
| OABI | SELL | 2025-12-08 | 2025-12-09 | $1.96 | $27K | +6.1% | -4.1% | -1.0% |
| OABI | SELL | 2025-04-07 | 2025-04-07 | $2.00 | $39K | -17.5% | -29.5% | -13.8% |
| OABI | SELL | 2025-02-18 | 2025-02-19 | $3.67 | $246K | -6.3% | -30.7% | -57.8% |
| OABI | SELL | 2025-01-21 | 2025-01-22 | $3.24 | $271K | +0.9% | +15.1% | -42.3% |
| OABI | SELL | 2024-12-09 | 2024-12-10 | $4.13 | $113K | -15.3% | -16.7% | -21.3% |
| OABI | BUY | 2024-05-24 | 2024-05-28 | $4.42 | $1.1M | +3.1% | -16.2% | -2.7% |
| OABI | BUY | 2024-03-22 | 2024-03-25 | $5.19 | $1.2M | -0.6% | -14.6% | -24.0% |
| OABI | BUY | 2023-12-12 | 2023-12-13 | $5.05 | $1.0M | +11.5% | +13.1% | -2.5% |
| OABI | BUY | 2023-11-10 | 2023-11-13 | $4.27 | $811K | -3.5% | +18.9% | +20.6% |
| OABI | BUY | 2023-08-14 | 2023-08-15 | $5.48 | $493K | -2.1% | -9.2% | -23.2% |
| OABI | BUY | 2023-06-09 | 2023-06-12 | $4.52 | $1.0M | +1.1% | +4.0% | +11.3% |
| OABI | BUY | 2023-05-12 | 2023-05-15 | $3.40 | $1.5M | +11.8% | +29.2% | +46.1% |
| OABI | BUY | 2022-12-12 | 2022-12-14 | $3.77 | $566K | -1.1% | +2.7% | -5.1% |
| OABI | BUY | 2022-11-30 | 2022-12-01 | $3.39 | $1.0M | +4.4% | -5.2% | +13.3% |
| OABI | BUY | 2022-11-09 | 2022-11-09 | $2.76 | $276K | +0.0% | +22.4% | +38.6% |
| LGND | BUY | 2022-05-13 | 2022-05-13 | $82.76 | $207K | -3.3% | -13.4% | +18.5% |
| VKTX | BUY | 2022-05-02 | 2022-05-03 | $2.47 | $222K | -11.7% | -15.5% | +8.7% |
| LGND | SELL | 2021-11-11 | 2021-11-12 | $163.02 | $3.6M | +0.4% | -11.0% | -25.7% |
| LGND | SELL | 2021-08-04 | 2021-08-05 | $109.67 | $1.9M | -1.3% | +21.3% | +47.2% |
| VKTX | BUY | 2021-06-10 | 2021-06-10 | $5.69 | $228K | +1.7% | +4.5% | +10.6% |
| LGND | SELL | 2021-02-04 | 2021-02-05 | $176.86 | $15.8M | -29.0% | -31.7% | -38.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| 43,659 |
| — |
| Total | $73.1M |
Shares reported on the most recent Form 4, priced at the 2026-04-07 close. 3 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.